Michael Linenberger

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Joseph E. Schwartz, Jeffrey L. Winters, Anand Padmanabhan et al. · Journal of Clinical Apheresis · 2013 · 593 citations

Evidence-based Therapy, Writing Committee, Patient Safety +12

Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

Zbigniew M. Szczepiorkowski, Nicholas Bandarenko, Haewon C. Kim et al. · Journal of Clinical Apheresis · 2007 · 545 citations

Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis

Zbigniew M. Szczepiorkowski, Jeffrey L. Winters, Nicholas Bandarenko et al. · Journal of Clinical Apheresis · 2010 · 500 citations

Clinical Disorders, Rheumatology, Health Sciences +14

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin

Michael Linenberger, Tom C. Hong, David Flowers et al. · Blood · 2001 · 198 citations · Full text

Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia

Daniella Kerbauy, Theodore A. Gooley, George E. Sale et al. · Biology of Blood and Marrow Transplantation · 2007 · 179 citations